Search research articles
Contact Us
Filters
Showing results (71-80 of 176) with videos related to
Page
of 18
Sort By:
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation
|
September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years
G Andreola, M Labopin, D Beelen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas
K Bouabdallah, S Furst, J Asselineau, et al.
Bone Marrow Transplantation
|
November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity
T Guillaume, B Gaugler, P Chevallier, et al.
Bone Marrow Transplantation
|
May 17, 2016
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
P Tsirigotis, I Danylesko, K Gkirkas, et al.
Transfusion
|
March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level
V Ivanov, C Faucher, M Mohty, et al.
Bone Marrow Transplantation
|
April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
P Chevallier, M Labopin, A Nagler, et al.
Journal of Hematology & Oncology
|
January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Simona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation
|
November 19, 2013
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality
M Labopin, N-C Gorin, E Polge, et al.
Page
of 18
Search research articles
Search
Showing results (71-80 of 176) with videos related to
Sort By:
Page
of 18
Leukemia
|
June 18, 2015
Outcome of allogeneic hematopoietic stem-cell transplantation for adult patients with AML and 11q23/MLL rearrangement (MLL-r AML)
A Pigneux, M Labopin, J Maertens, et al.
Bone Marrow Transplantation
|
April 9, 2014
Use of G-CSF to hasten neutrophil recovery after auto-SCT for AML is not associated with increased relapse incidence: a report from the Acute Leukemia Working Party of the EBMT
T Czerw, M Labopin, N-C Gorin, et al.
Bone Marrow Transplantation
|
September 22, 2015
Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years
G Andreola, M Labopin, D Beelen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 2, 2014
90Y-ibritumomab tiuxetan, fludarabine, busulfan and antithymocyte globulin reduced-intensity allogeneic transplant conditioning for patients with advanced and high-risk B-cell lymphomas
K Bouabdallah, S Furst, J Asselineau, et al.
Bone Marrow Transplantation
|
November 29, 2011
Escalated lymphodepletion followed by donor lymphocyte infusion can induce a graft-versus-host response without overwhelming toxicity
T Guillaume, B Gaugler, P Chevallier, et al.
Bone Marrow Transplantation
|
May 17, 2016
Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation
P Tsirigotis, I Danylesko, K Gkirkas, et al.
Transfusion
|
March 27, 2004
Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level
V Ivanov, C Faucher, M Mohty, et al.
Bone Marrow Transplantation
|
April 8, 2009
Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT
P Chevallier, M Labopin, A Nagler, et al.
Journal of Hematology & Oncology
|
January 21, 2017
A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia
Simona Piemontese, F Ciceri, M Labopin, et al.
Bone Marrow Transplantation
|
November 19, 2013
A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality
M Labopin, N-C Gorin, E Polge, et al.
Page
of 18